BCL7C 抗体 (AbBy Fluor® 350)
Quick Overview for BCL7C 抗体 (AbBy Fluor® 350) (ABIN2170554)
抗原
See all BCL7C 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            交叉反应
- 人, 小鼠, 大鼠
- 
                                            纯化方法
- Purified by Protein A.
- 
                                            免疫原
- KLH conjugated synthetic peptide derived from human BCL7C
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- IF(IHC-P) 1:50-200
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 μg/μL
- 
                                            缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - BCL7C (B-Cell CLL/lymphoma 7C (BCL7C))
- 
                                            别名
- BCL7C
- 
                                            背景
- 
                        Synonyms: B cell CLL/lymphoma 7 protein family member C, B cell CLL/lymphoma 7C, B-cell CLL/lymphoma 7 protein family member C, BCL 7C, Bcl7c, BCL7C_HUMAN. Background: May play an anti-apoptotic role. 
- 
                                            基因ID
- 9274
 抗原
- 
                    
 
                                     
                                     
                                    